Sacral

Top Story

Adalimumab, IBI303 biosimilar demonstrate comparable safety, efficacy in AS

September 19, 2019
In the Journals

Newly diagnosed cases of AS at increased risk for IMIDs, lower risk for RA

September 16, 2019
Newly diagnosed patients with ankylosing spondylitis in Taiwan demonstrate increased risks for multiple immune-mediated inflammatory diseases, including acute anterior…
FDA News

FDA expands Taltz approval for ankylosing spondylitis

August 26, 2019
The FDA has extended approval for ixekizumab injection 80 mg/mL to treat adults with ankylosing spondylitis – or radiographic axial spondyloarthritis - according…
In the JournalsPerspective

ACR cautions against mandated biosimilar switching for AS, axSpA

August 22, 2019
Adults with active ankylosing spondylitis despite treatment with a first TNF-inhibitor, as well as those with stable disease receiving an originator TNF inhibitor…
More Headlines »
Cover Story

Surgeons should educate each other on the hip-spine connection

Orthopedics Today, June 2019
The belief that the spine moves independently of the pelvis and hip has been disproved in recent years as researchers…
More »
Video
Meeting News Coverage

Babar Kayani, MBBS, BSc, comments on rare sacral chordomas

March 21, 2014
More »